358 related articles for article (PubMed ID: 8635375)
21. Effects of nedocromil sodium, cromolyn sodium, and a placebo in exercise-induced asthma.
Morton AR; Ogle SL; Fitch KD
Ann Allergy; 1992 Feb; 68(2):143-8. PubMed ID: 1310834
[TBL] [Abstract][Full Text] [Related]
22. Effects of adding nedocromil sodium (Tilade) to the routine therapy of patients with bronchial asthma.
Fyans PG; Chatterjee PC; Chatterjee SS
Clin Exp Allergy; 1989 Sep; 19(5):521-8. PubMed ID: 2551469
[TBL] [Abstract][Full Text] [Related]
23. A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma.
Fairfax AJ; Allbeson M
J Int Med Res; 1988; 16(3):216-24. PubMed ID: 2842206
[TBL] [Abstract][Full Text] [Related]
24. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group.
Jones PW
Eur Respir J; 1994 Jan; 7(1):55-62. PubMed ID: 8143833
[TBL] [Abstract][Full Text] [Related]
25. Controlled trial of two formulations of cromolyn sodium in the treatment of asthmatic patients > or = 12 years of age. Intal Study Group.
Furukawa C; Atkinson D; Forster TJ; Nazzario K; Simpson B; Uryniak T; Casty FE
Chest; 1999 Jul; 116(1):65-72. PubMed ID: 10424505
[TBL] [Abstract][Full Text] [Related]
26. Nedocromil sodium and placebo in the treatment of bronchial asthma. A multicenter, double-blind, parallel-group comparison.
Greif J; Fink G; Smorzik Y; Topilsky M; Bruderman I; Spitzer SA
Chest; 1989 Sep; 96(3):583-8. PubMed ID: 2548815
[TBL] [Abstract][Full Text] [Related]
27. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of nedocromil sodium versus placebo in chronic reversible obstructive airways disease.
Del Bufalo C; Fasano L; Fabbri M; Quarta CC; Gunella G
J Investig Allergol Clin Immunol; 1993; 3(3):136-41. PubMed ID: 8281343
[TBL] [Abstract][Full Text] [Related]
29. Nedocromil in the outpatient management of asthma.
Keenan JM; Bielory L; Flamion PC; Ford LB; Murcek M; Pyszczynski DR; Selcow J; Silvagni A; Tarpay M; Zitt MJ
Arch Fam Med; 1995 Oct; 4(10):835-42; discussion 843. PubMed ID: 7551130
[TBL] [Abstract][Full Text] [Related]
30. A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.
el Hennawi M
Br J Ophthalmol; 1994 May; 78(5):365-9. PubMed ID: 8025071
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium.
Robuschi M; Gambaro G; Sestini P; Pieroni MG; Refini RM; Vaghi A; Bianco S
Am J Respir Crit Care Med; 1997 Apr; 155(4):1461-4. PubMed ID: 9105094
[TBL] [Abstract][Full Text] [Related]
32. Dissociation in the effect of nedocromil on mannitol-induced cough or bronchoconstriction in asthmatic subjects.
Koskela HO; Martens R; Brannan JD; Anderson SD; Leuppi J; Chan HK
Respirology; 2005 Sep; 10(4):442-8. PubMed ID: 16135166
[TBL] [Abstract][Full Text] [Related]
33. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma.
Boldy DA; Ayres JG
Respir Med; 1993 Oct; 87(7):517-23. PubMed ID: 8265839
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of budesonide or nedocromil in children with asthma.
; Szefler S; Weiss S; Tonascia J; Adkinson NF; Bender B; Cherniack R; Donithan M; Kelly HW; Reisman J; Shapiro GG; Sternberg AL; Strunk R; Taggart V; Van Natta M; Wise R; Wu M; Zeiger R
N Engl J Med; 2000 Oct; 343(15):1054-63. PubMed ID: 11027739
[TBL] [Abstract][Full Text] [Related]
35. [Nedocromil sodium therapy in asthma patients. Therapeutic effect in addition to treatment with oral theophylline and inhaled bronchodilator agents].
Boos R; van Kampen C; Weede W; Beck W
Fortschr Med; 1989 Nov; 107(33):712-6. PubMed ID: 2557274
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial.
Blumenthal MN; Casale TB; Fink JN; Uryniak T; Casty FE
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):7-13. PubMed ID: 9449494
[TBL] [Abstract][Full Text] [Related]
37. A double-blind comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in patients routinely using oral bronchodilators.
Cua-Lim F; Agbayani BF; Lachica D
Eur J Respir Dis Suppl; 1986; 147():306-10. PubMed ID: 3021498
[TBL] [Abstract][Full Text] [Related]
38. Double blind, placebo controlled study of nedocromil sodium in asthma.
Armenio L; Baldini G; Bardare M; Boner A; Burgio R; Cavagni G; La Rosa M; Marcucci F; Miraglia del Giudice M; Pulejo MR
Arch Dis Child; 1993 Feb; 68(2):193-7. PubMed ID: 8386917
[TBL] [Abstract][Full Text] [Related]
39. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate.
Dixon CM; Barnes PJ
Br J Clin Pharmacol; 1989 Jun; 27(6):831-6. PubMed ID: 2547408
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study.
Meltzer EO;
Clin Ther; 2002 Jun; 24(6):942-52. PubMed ID: 12117084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
